Literature DB >> 20694280

The vessel wall: A forgotten player in post thrombotic syndrome.

Scott Deroo1, K Barry Deatrick, Peter K Henke.   

Abstract

Much research in venous thrombotic diseases focuses on the acute thrombotic process such as anticoagulation and risk factors. Deep-vein thrombosis directly leads to post thrombotic syndrome, and this can cause significant patient disability. Little research has focused on the vein wall injury response to the thrombotic inflammatory insult. Herein, we review what is currently known about this process with emphasis on the matrix, mediators, and vascular medial smooth muscle response after thrombotic injury. Translational therapies and potential future agents are reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694280     DOI: 10.1160/TH10-03-0183

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

Review 1.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

Review 2.  Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art.

Authors:  Akhilesh K Sista; Suresh Vedantham; John A Kaufman; David C Madoff
Journal:  Radiology       Date:  2015-07       Impact factor: 11.105

Review 3.  The role of thrombolysis in the clinical management of deep vein thrombosis.

Authors:  Radha Krishna Popuri; Suresh Vedantham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

4.  Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome?

Authors:  Stefano de Franciscis; Luca Gallelli; Bruno Amato; Lucia Butrico; Alessio Rossi; Gianluca Buffone; Francesco G Caliò; Giovanni De Caridi; Raffaele Grande; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

5.  Ly6CLo Monocyte/Macrophages are Essential for Thrombus Resolution in a Murine Model of Venous Thrombosis.

Authors:  Andrew Scott Kimball; Andrea Tara Obi; Catherine E Luke; Abigail R Dowling; Qing Cai; Reheman Adili; Hannah Jankowski; Matthew Schaller; Michael Holinstadt; Farouc A Jaffer; Steven L Kunkel; Katherine A Gallagher; Peter K Henke
Journal:  Thromb Haemost       Date:  2019-12-30       Impact factor: 5.249

6.  The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.

Authors:  Joe F Baldwin; Vikram Sood; Megan A Elfline; Cathy E Luke; Nicholas A Dewyer; Jose A Diaz; Dan D Myers; Thomas Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2012-07-15       Impact factor: 4.268

7.  Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.

Authors:  Wenzhu Li; Chase W Kessinger; Makoto Orii; Hang Lee; Lang Wang; Ido Weinberg; Michael R Jaff; Guy L Reed; Peter Libby; Ahmed Tawakol; Peter K Henke; Farouc A Jaffer
Journal:  Circulation       Date:  2021-01-15       Impact factor: 29.690

8.  Statins improve the resolution of established murine venous thrombosis: reductions in thrombus burden and vein wall scarring.

Authors:  Chase W Kessinger; Jin Won Kim; Peter K Henke; Brian Thompson; Jason R McCarthy; Tetsuya Hara; Martin Sillesen; Ronan J P Margey; Peter Libby; Ralph Weissleder; Charles P Lin; Farouc A Jaffer
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

9.  Interventional treatment of postthrombotic syndrome.

Authors:  H Jalaie; K Schleimer; M E Barbati; A Gombert; J Grommes; M A F de Wolf; R de Graaf; C H A Wittens
Journal:  Gefasschirurgie       Date:  2016-07-12

Review 10.  Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.

Authors:  J Matthew Nicklas; Aviva E Gordon; Peter K Henke
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.